Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00961
   Synonyms SPAAR, LINC00961, SPARï¼?lin-RECK-3
   Region GRCh38_9:35909483-35937153    Sequence
   Ensembl ENSG00000235387
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name non small cell lung cancer
   ICD-0-3 C34  M8046/3
   Methods qPCR, Western blot
   Sample NSCLC tissue, cell lines (SPC-A1, A549, PC9, NCI-H1299, NCI-H1975, SK-MES-1, 16HBE)
   Expression Pattern down-regulated
   Function Description

Decreased LINC00961 was associated with NSCLC patients advanced clinical stage, lymph node metastasis, and shorter survival time. LSD1 could directly bind to LINC00961 promoter regions and epigenetically repress its transcription in NSCLC cells.Ectopic overexpression of LINC00961 inhibits NSCLC cell migration,invasion in vitro and metastasis in vivo. LINC00961 could act as a tumor suppressor partially via affecting B-catenin expression. Collectively, decreased LINC00961 might play a key role in NSCLC progression, and may serve as a novel prognostic marker in human NSCLC.

   Pubmed ID 29156520
   Year 2017
   Title Long noncoding RNA LINC00961 inhibits cell invasion and metastasis in human non-small cell lung cancer.
   External Links
   Links for  LINC00961 GenBank       HGNC       lncrnadb       Noncode
   Links for  non small cell lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.